/

Società

AS

Società

ASABYS

Di cosa scriviamo

Auto/AutomotiveIngegneriaSaluteSanitàUniversità

30 comunicati stampa

Guarda tutti i comunicati

Press Release cover image

25/02/2026

Università

Salute

Sanità

Medasense Appoints MedTech Leader Peter Wehrly as Executive Chairman of the Board - Asabys Partners

Fonte

1.00

0

Press Release cover image

03/02/2026

Salute

Sanità

Asabys-backed Oriva Therapeutics launches to advance novel treatments for women’s health - Asabys Partners

Fonte

1.00

0

Press Release cover image

22/01/2026

Salute

Sanità

Asabys-backed Oriva Therapeutics launches to advance novel treatments for women’s health - Asabys Partners

Fonte

1.00

0

Press Release cover image

13/01/2026

Salute

Sanità

SafeHeal® Announces Successful Launch of SAFE-3CV IDE Study for Colovac® Anastomosis Protection Technology - Asabys Partners

Fonte

1.00

0

Press Release cover image

09/01/2026

Salute

Sanità

Agomab Announces Positive Phase 1 Interim Results with AGMB-447 in Healthy Participants and Initiation of Idiopathic Pulmonary Fibrosis Cohort - Asabys Partners

Fonte

1.00

0

Press Release cover image

09/12/2025

Salute

Sanità

INBRAIN Neuroelectronics Appoints Scott Huennekens as Chairman of the Board - Asabys Partners

Fonte

1.00

0

Press Release cover image

17/11/2025

Salute

Sanità

Agomab Announces Positive Topline Phase 2a Data for Ontunisertib in Fibrostenosing Crohn’s Disease - Asabys Partners

Fonte

1.00

0

Press Release cover image

04/11/2025

Economia

Economia internazionale

Salute

Sport

Qida raises €37 million to continue improving the quality of life of the senior segment at home - Asabys Partners

Fonte

1.00

0

Press Release cover image

14/10/2025

Salute

Oncologia

Sanità

Ona Therapeutics, a portfolio company of Asabys Partners and Alta Life Sciences, appoints Dr. Antoine Yver as Chair of the Board to accelerate its ADC programs towards clinical development - Asabys Partners

Fonte

1.00

0

Press Release cover image

10/09/2025

Salute

Sanità

Asabys Partners Leads €10 Million Extension of SafeHeal’s Oversubscribed Series C Financing to Accelerate Commercialization of Colovac® - Asabys Partners

Fonte

1.00

0

Seguaci

0

Compatibilità

0